photo
Speaker

Manuel Vega, PhD

CEO, AGS THERAPEUTICS
Paris, France
PhD in Biology, Universidad Nacional del Sur, Argentina - 1987.
Director Development & Production (viral vectors for gene therapy) - Genethon (France) - 1997 - 1999.
Founder CEO - Nautilus Biotech (France) and Nautilus Technology (USA) - 2000 - 2008.
Founder CEO - Markets & Listing (France) - 2015 to date.
Founder CEO - AGS (France) - 2020 to date.
Speaking In
9:15 AM - 9:30 AM (EST)
Tuesday, February 7
AGS develops a pipeline of innovative therapeutics to address life-threatening conditions, based on…
Winter Garden